(2026)
Evaluating the Feasibility of an Electronic Patient-Reported Outcomes Platform Integrating Electronic Health Records and a Mobile Messaging App in Breast Cancer Radiotherapy: Retrospective Cross-Sectional Study.
JMIR MHEALTH AND UHEALTH.
14,
e67514
(2026)
Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion.
BREAST CANCER RESEARCH AND TREATMENT.
215,
3
(2025)
Significant Influence of Cardiac Radiation Dose on the Risk of Cardiotoxicity in Patients Receiving Adjuvant Trastuzumab and Radiation Therapy for Breast Cancer.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
122,
5
(2025)
Concurrent Versus Sequential Adjuvant Capecitabine-Based Chemoradiation in Residual Triple-Negative Breast Cancer After Neoadjuvant-Chemotherapy: A Multicenter Comparative Study.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
122,
1
(2025)
Predicting 30-day mortality with routine blood tests in patients undergoing palliative radiation therapy: A comparison of logistic regression and gradient boosting models.
RADIOTHERAPY AND ONCOLOGY.
206,
1
(2025)
A device-dependent auto-segmentation method based on combined generalized and single-device datasets.
MEDICAL PHYSICS.
52,
4
(2025)
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
121,
2
(2025)
Patient-Reported Outcomes Between Whole-Breast Plus Regional Irradiation and Whole-Breast Irradiation Only in pN1 Breast Cancer After Breast-Conserving Surgery and Taxane-Based Chemotherapy: A Randomized Phase 3 Clinical Trial (KROG 17-01).
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
121,
2
(2024)
Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapy.
Radiation Oncology Journal.
42,
3
(2024)
Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boost.
MEDICAL DOSIMETRY.
49,
2
(2024)
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants.
BREAST CANCER.
31,
3
(2024)
Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study.
CANCER RESEARCH AND TREATMENT.
56,
2
(2024)
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response.
JOURNAL OF BREAST CANCER.
27,
2
(2024)
Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
BREAST CANCER RESEARCH AND TREATMENT.
203,
3
(2024)
Traffic Exposure and Breast Cancer Mortality by Area of Residence: Incorporating Clinical and Socioeconomic Data.
Studies in Health Technology and Informatics.
310,
(2024)
Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery.
SCIENTIFIC REPORTS.
14,
1
(2024)
Quantitative assessment of breast volume changes after whole-breast irradiation for breast cancer using breast auto-segmentation.
BREAST CANCER RESEARCH AND TREATMENT.
203,
2
(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer.
BREAST.
72,
1
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
학술회의논문
(2023)
Implication of Pre- and Post-Radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study.
Radiation Oncology Journal.
대한민국
(2023)
Multidimensional longitudinal assessment of toxicity and cosmesis after hypofractionated whole-breast radiotherapy for breast cancer among a prospective cohort of Korean women: a preliminary result.
Radiation Oncology Journal.
대한민국
(2023)
Optimal Radiation Therapy Field in Clinically Node-Positive Breast Cancer Patients after Neoadjuvant Chemotherapy and Sentinel Lymph Node Biopsy.
Radiation Oncology Journal.
대한민국
(2023)
Quantitative Assessment of Breast Volume Change after Whole-Breast Irradiation for Breast Cancer: A Study Using Deep-Learning-Driven Breast Auto-segmentation .
Radiation Oncology Journal.
대한민국
(2023)
The Role of Oncotype DX Risk Score in Determining Radiation Therapy Field for Early Breast Cancer.
Radiation Oncology Journal.
대한민국
(2020)
Impact of radiotherapy timing on breast cancer outcome in patients underwent mastectomy and immediate breast reconstruction.
대한방사선종양학회 추계학회.
대한민국
발전기금
